Janux Therapeutics, Inc. (JANX)

Janux Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	48.39	430.61	19.21	51.43	35.58	7.81
Short-Term Investments	940.6	594.57	324.82	275.59	339.38	-
Cash & Short-Term Investments	988.99	1,025	344.03	327.02	374.97	7.81
Cash Growth	50.30%	197.99%	5.20%	-12.79%	4699.24%	1087.39%
Accounts Receivable	-	-	-	-	-	8
Other Receivables	6.32	5.38	2.16	0.7	0.2	-
Receivables	6.32	5.38	2.16	0.7	0.2	8
Prepaid Expenses	2.78	3.11	3.05	4.72	1.85	0.25
Total Current Assets	998.09	1,034	349.24	332.44	377.02	16.06
Property, Plant & Equipment	23.24	24.15	27.84	29.37	1.6	0.16
Other Long-Term Assets	3.44	3.7	3.33	2.21	1.21	-
Total Assets	1,025	1,062	380.41	364.01	379.82	16.22
Accounts Payable	3.4	4.03	2.42	2.16	2.46	0.43
Accrued Expenses	22.16	11.68	7.39	8.18	3.78	0.75
Current Portion of Leases	2.28	1.75	1.52	0.76	0.19	-
Current Unearned Revenue	-	-	1.71	5.41	5.16	1.95
Other Current Liabilities	-	-	-	-	1.2	0.05
Total Current Liabilities	27.83	17.46	13.03	16.51	12.8	3.18
Long-Term Leases	20.38	21.28	23.03	24.54	-	-
Long-Term Unearned Revenue	-	-	-	2.22	0.7	6.05
Total Liabilities	48.21	38.74	36.06	43.27	13.5	9.23
Common Stock	0.06	0.06	0.05	0.04	0.04	0
Additional Paid-In Capital	1,291	1,258	512.4	432.7	413.97	0.1
Retained Earnings	-319.44	-237.76	-168.76	-110.47	-47.41	-14.74
Comprehensive Income & Other	4.56	2.16	0.67	-1.54	-0.27	-
Total Common Equity	976.56	1,023	344.35	320.74	366.33	-14.64
Shareholders' Equity	976.56	1,023	344.35	320.74	366.33	6.99
Total Liabilities & Equity	1,025	1,062	380.41	364.01	379.82	16.22
Total Debt	22.66	23.03	24.54	25.31	0.19	-
Net Cash (Debt)	966.33	1,002	319.49	301.71	374.77	7.81
Net Cash Growth	52.27%	213.68%	5.89%	-19.50%	4696.76%	-
Net Cash Per Share	15.93	18.64	7.26	7.28	15.93	8.54
Filing Date Shares Outstanding	60.15	59.11	51.65	41.76	41.24	1.26
Total Common Shares Outstanding	60.12	59.06	46.24	41.62	41.24	1.26
Working Capital	970.26	1,016	336.21	315.93	364.22	12.88
Book Value Per Share	16.24	17.32	7.45	7.71	8.88	-11.64
Tangible Book Value	976.56	1,023	344.35	320.74	366.33	-14.64
Tangible Book Value Per Share	16.24	17.32	7.45	7.71	8.88	-11.64
Machinery	10.73	9.81	9.87	7.91	1.4	0.18
Construction In Progress	-	-	-	-	0.14	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q